Skip to main content
Signal8

BIOREGENX, INC. (BRGX)

BioRegenx, Inc. develops, manufactures, and sells medical test equipment, science-based nutritional products, and AI-driven health monitoring technologies. Its products include the GlycoCheck system for microvascular health assessment, the Endocalyx Pro dietary supplement, and the DocSun AI engine for contactless vital sign monitoring. The company focuses on regenerative biotherapeutics, anti-aging, and non-invasive medical and wellness devices.

Sector: Services-Computer Programming, Data Processing, Etc.

Industry: Medical - Instruments & Supplies

BioRegenx, Inc. logo

BioRegenx, Inc.

OTC:BRGXTechnology
$0.0002
Mkt Cap$194K
Float322.23M
O/S971.58M
Inst Own-
SI0.1%
Dilution
FormDescription
10-Q
NT 10-Q
EXTENSION
3
10-K
FORM 10-K FOR DEC 2025
NT 10-K
EXTENSION
10-Q
FORM 10-Q FOR SEP 2025
10-Q
FORM 10-Q FOR JUNE 2025
10-Q
FORM 10-Q FOR MAR 2025
10-K/A
FORM 10-K FOR DEC 2024
10-K
FORM 10-K FOR DEC 2024
8-K
5.02
NT 10-K
SEC Filing
8-K
5.02
3
Initial Statement of Beneficial Ownership
10-Q
FROM 10-Q FOR SEPT 2024
8-K
5.02
10-Q
FORM 10-Q FOR JUNE 2024
10-Q/A
FORM 10-Q AMENDMENT 2
8-K/A
2.01,3.02,5.01,5.02,5.03,9.01
NT 10-Q
EXTENSION
8-K
CURRENT REPORT
CORRESP
SEC Filing
13D/A
AMENDMENT TO SCHEDULE 13D
CORRESP
SEC Filing
13D/A
AMENDMENT TO SCHEDULE 13D
CORRESP
SEC Filing

1-25 of 107